Blood Outgrowth Endothelial Cells as a Cellular Carrier for Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Preclinical Models of Non-Small Cell Lung Cancer
Oncolytic viruses have demonstrated efficacy in numerous tumor models including non-small cell lung cancer (NSCLC). One limitation of viral therapy for metastatic lung cancer is that systemic administration can be hindered by complement and antiviral immunity. Thus, we investigated whether ex vivo-i...
Main Authors: | Manish R. Patel, Blake A. Jacobson, Yan Ji, Robert P. Hebbel, Robert A. Kratzke |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523320302631 |
Similar Items
-
Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity
by: Marie-Claude Bourgeois-Daigneault, et al.
Published: (2016-01-01) -
Diversity in responses to oncolytic Lassa-vesicular stomatitis virus in patient-derived glioblastoma cells
by: Teddy E. Kim, et al.
Published: (2021-09-01) -
N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells
by: Juan C Corredor, et al.
Published: (2016-01-01) -
Differential infection of murine and human dendritic cell subsets by oncolytic vesicular stomatitis virus variants
by: Lisa Pipperger, et al.
Published: (2021-01-01) -
Experimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.
by: Raquel Garijo, et al.
Published: (2014-01-01)